NEW YEAR’S MESSAGE FROM LRA PRESIDENT & CEOAs we welcome in the new year, hear from Lupus Research Alliance President & CEO Albert Roy how 2022 was a time of remarkable progress and why 2023 holds tremendous promise for lupus discovery and treatment advances.Al’s recap of last year’s accomplishments demonstrates how the LRA and our […] READ MORE
NEW YORK, NY, Dec. 14, 2022. The Lupus Research Alliance (LRA) proudly announces the two outstanding recipients of the 2022 Distinguished Innovator Award (DIA): Hongbo Chi, PhD, and Joseph Craft, MD. Both awards are focused on studying distinct T cell populations in lupus which aligns with LRA’s strategic objective to accelerate breakthrough treatments and ultimately […] READ MORE
November, 2022 The Lupus Research Alliance (LRA) aims to support the best science to prevent, treat and cure lupus. This year during the annual American College of Rheumatology conference, ACR Convergence 2022, which took place from November 10 – 14 in Philadelphia, PA, more than 30 LRA-funded studies were presented by researchers to thousands of […] READ MORE
New York, NY. November 22, 2022 – Last night’s Lupus Research Alliance (LRA) Breaking Through Gala at Manhattan’s historic Ziegfeld Ballroom was both inspiring and successful, raising more than $4 million for lupus research. More than 600 people turned out to recognize 2022 Gala honoree Leslie D. Hale, President & Chief Executive Officer at RLJ […] READ MORE
ACR Convergence 2022 Included LRA-Authored Research on Measures to Demonstrate Treatment Efficacy for Patients with Lupus NEW YORK, NY–November 8, 2022 — The Lupus Research Alliance and its affiliate Lupus Therapeutics will present data at ACR Convergence 2022 with results showing the effectiveness of a pilot peer education program called the Patient Advocates for Lupus […] READ MORE
November 10, 2022 As you probably know, the LRA and our advocates were highly instrumental in creating the Department of Defense Lupus Research Program in 2017 and in increasing its budget over the years since. We are working to increase LRP funding even more to $15 million – and this is the time to make […] READ MORE
November 2, 2022 Last Sunday brought major fundraising support to the Lupus Research Alliance (LRA) during Lupus Awareness Day at the New York Jets game against rival New England Patriots. WATCH this pregame interview on SNY with Jets Chairman and LRA Founding Chairman Robert Wood “Woody” Johnson IV talking about how far lupus research has come […] READ MORE
October 26, 2022 The New York Jets and Lupus Research Alliance will host Lupus Awareness Day on October 30, 2022, at MetLife Stadium when the Jets take on the New England Patriots. This event is designed to increase awareness of the devastating autoimmune disease and help raise funds supporting lupus research for new treatments and […] READ MORE
October 18, 2022 Ten years ago, Megan Rosa struggled to walk because of her lupus – now she’s training for the race of a lifetime – the 26.2 mile NYC TCS Marathon! How and why she is running to fundraise for the Lupus Research Alliance is one of the most inspiring stories we’ve heard from […] READ MORE
September 21, 2022 Lupkynis® (voclosporin) was just granted marketing authorization in the European Union as a new treatment for adults with lupus nephritis, the kidney damage associated with lupus. The drug had also been approved this past January in the U.S. to treat adults with lupus nephritis in combination with a background immunosuppressive medication in […] READ MORE
September 21, 2022 Results of a small study published in the prestigious journal Nature Medicine, suggest that a type of immune cell therapy called chimeric antigen receptor (CAR) T cell therapy could become a highly effective therapy for SLE patients who do not respond to current lupus treatments. CD19 CAR T cells are T cells that […] READ MORE
September 7, 2022 The New York Jets 2022 football season kicked off last week with a spectacular luncheon that raised $740,000 for the Lupus Research Alliance and the New York Jets Foundation. The event also honored our former President and CEO Kenneth Farber for his years of commitment and progress in lupus research. Continuing as […] READ MORE
